“In the multitude of counsellors there is safety.”
-- Proverbs xi.14.
CDER’s Office of Surveillance and Epidemiology has been raised to the level of a a “super-office” to provide (at least in theory) greater management support to the unit’s growing staff and responsibilities.
As outlined by Super CDER Director Janet Woodcock, OSE will become a super-office that houses two new subordinate offices. According to Janet, “As OSE continues to build capacity and take on new responsibilities, and as the breadth, depth and volume of its work continue to increase, we need an organizational structure that provides adequate management support for these vital program areas.”
The changes will result in a new layer of management, in the form of the two new offices under OSE, which will have their own directors and deputy directors. The creation of a second epidemiology division, with its own director and deputy director, also will provide additional management support.
The Pink Sheet opines that, “The reorganization opens the door to a leadership change atop OSE.” Although OSE’s current director, Gerald Dal Pan, will serve as acting director of the new super-office, FDA will conduct a nationwide search for a permanent director.
“There is no safety in numbers – or in anything else.”
-- James Thurber
